Sort
48,018 grants matching “immunotherapy”
Immunological and Microbial Mechanisms in Food Allergy
$627,598Talal Amine Chatila · Boston Children'S Hospital · R01 · FY2024 · AI
Immunological and Microbial Mechanisms in Food Allergy
$627,598Talal Amine Chatila · Boston Children'S Hospital · R01 · FY2023 · AI
Development of a 3D multi-modal perfusion-thermal electrode system
$627,588Xiaoming Yang · University Of Washington · R01 · FY2020 · EB
A New Multimodal Molecular Imaging Approach to Guide Intra-Operative Tumor Resection and Post-Operative Treatment Planning
$627,585Cristina L. Zavaleta · University Of Southern California · R01 · FY2023 · EB
Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer
$627,562Guangfu Li · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$627,467Rongfu Wang · University Of Southern California · R01 · FY2023 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$627,467Rongfu Wang · University Of Southern California · R01 · FY2022 · CA
iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma
$627,456Jared Weiss · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Regulatory T Cells and Pulmonary Hypertension
$627,446Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2022 · HL
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$627,404Harry H Yoon · Mayo Clinic Rochester · R01 · FY2025 · CA
Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy
$627,344Ruijiang Li · Stanford University · R01 · FY2025 · CA
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors
$627,272Denis Wirtz · Johns Hopkins University · R01 · FY2025 · CA
Structure, Function and Antigenicity of Coronavirus Spike Proteins
$627,157Jason Scott McLellan · University Of Texas At Austin · R01 · FY2018 · AI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$627,098Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2019 · CA
Improved Treatment of American Cutaneous Leishmaniasis by Immunomodulation
$627,013Diane McMahon Pratt · Yale University · R01 · FY2013 · AI
IDO1 and Immunotolerance in Glioblastoma
$627,010Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2021 · NS
Depleting exosomes to improve responses to immune therapy in HNSCC
$627,000Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · DE
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
$626,964Arash Ash Alizadeh · Stanford University · U01 · FY2015 · CA
Phase I Clinical Trials of Anticancer Agents
$626,936Charles Erlichman · Mayo Clinic Rochester · U01 · FY2007 · CA
Pathogenesis of Food Allergy
$626,919Pamela Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2023 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2022 · CA
Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer
$626,815Dohun Pyeon · Michigan State University · R01 · FY2020 · DE
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles
$626,777Cristina L. Zavaleta · University Of Southern California · R01 · FY2025 · CA
Mouse models of Kras-mutant colorectal cancer
$626,771Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2023 · CA